Literature DB >> 18307696

Obesity and its related diseases in Taiwan.

K-C Huang1.   

Abstract

Obesity is related to increased morbidity and mortality, and prevails worldwide. It has become an important health issue and requires urgent attention. In Taiwan, overweight and obesity are defined as body mass index > or = 24 and 27 kg m(-2), respectively. These cut-offs differ from Caucasian standards, as Asians have higher comorbidities and fat mass at lower BMI levels than Caucasians. The prevalence of obesity and overweight in Taiwan are 19.2% and 30.5% in men, 13.4% and 21.3% in women. This implies that a more profound increase in obesity prevalence is found in men than in women. A high-fat diet, sedentary lifestyle and betel nut chewing may increase substantially this obesity epidemic. Recently, type 2 diabetes mellitus has been found to be the most common type of diabetes, and obesity is significantly related to type 2 diabetes in children. In addition, obesity is associated with cardiovascular diseases risk factors and cannot be neglected in elderly. Therefore, a comprehensive prevention and management programme of obesity is urgently warranted for controlling the growing obesity trend and its related diseases in Taiwan.

Entities:  

Mesh:

Year:  2008        PMID: 18307696     DOI: 10.1111/j.1467-789X.2007.00435.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  17 in total

1.  Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Aynur Unalp-Arida; Katherine Yates; Arun Sanyal; Cynthia Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

2.  Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes.

Authors:  Robert J Wong; Christina Chou; Sidhartha R Sinha; Ahmad Kamal; Aijaz Ahmed
Journal:  J Community Health       Date:  2014-06

3.  Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia.

Authors:  Seok-Chin Goh; Evelyn Lai-Ming Ho; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2012-03-23       Impact factor: 6.047

Review 4.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Authors:  Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2014-05-27

5.  The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists.

Authors:  Ryan T Hurt; Christopher Kulisek; Laura A Buchanan; Stephen A McClave
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

6.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

Review 7.  Association between metabolic factors and chronic hepatitis B virus infection.

Authors:  Chien-Hsieh Chiang; Kuo-Chin Huang
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population.

Authors:  Hung-Ju Lin; Bai-Chin Lee; Yi-Lwun Ho; Yen-Hung Lin; Ching-Yi Chen; Hsiu-Ching Hsu; Mao-Shin Lin; Kuo-Liong Chien; Ming-Fong Chen
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

9.  Preoperative Factors Associated with Extrathyroidal Extension in Papillary Thyroid Cancer.

Authors:  Chi-Yu Kuo; Po-Sheng Yang; Ming-Nan Chien; Shih-Ping Cheng
Journal:  Eur Thyroid J       Date:  2020-04-14

Review 10.  Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review.

Authors:  Elizabeth A Maull; Habibul Ahsan; Joshua Edwards; Matthew P Longnecker; Ana Navas-Acien; Jingbo Pi; Ellen K Silbergeld; Miroslav Styblo; Chin-Hsiao Tseng; Kristina A Thayer; Dana Loomis
Journal:  Environ Health Perspect       Date:  2012-08-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.